Stay updated on DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial
Sign up to get notified when there's something new on the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page.

Latest updates to the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed; no study content, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the banner about lapse in government funding and NIH operating status. The core study details and eligibility information on the page remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedNew screenshot shows a layout update with no changes to the study details, eligibility criteria, endpoints, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference7%

- Check70 days agoChange DetectedUpgrade page version to v3.1.0 and remove several MedlinePlus drug-safety topics and related MeSH terms (including Substandard Drugs and Counterfeit Drugs).SummaryDifference2%

- Check84 days agoChange DetectedMinor update: version bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed; no changes to core content, pricing, stock, or time-slot information.SummaryDifference0.4%

Stay in the know with updates to DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page.